China Universal Asset Management Company’s Immunocore IMCR Stock Holding History

China Universal Asset Management Company’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Sell	7,277 -3,506	-33%	-$104K	0.01%	342
2026 Q1	$325K	Sell	10,783 -4,326	-29%	-$140K	0.02%	304
2025 Q4	$524K	Buy	15,109 +8,088	+115%	+$286K	0.04%	256
2025 Q3	$255K	Sell	7,021 -961	-12%	-$32.6K	0.02%	313
2025 Q2	$250K	Buy	7,982 +35	+0.4%	+$1.09K	0.02%	292
2025 Q1	$236K	Sell	7,947 -446	-5%	-$13.4K	0.02%	297
2024 Q4	$248K	Buy	8,393 +960	+13%	+$30.4K	0.02%	312
2024 Q3	$231K	Buy	7,433 +3,053	+70%	+$111K	0.03%	289
2024 Q2	$148K	Sell	4,380 -2,241	-34%	-$114K	0.02%	271
2024 Q1	$430K	Buy	6,621 +2,721	+70%	+$187K	0.05%	197
2023 Q4	$266K	Buy	3,900 +3,064	+367%	+$159K	0.05%	182
2023 Q3	$43.4K	Buy	836 +426	+104%	+$25.2K	0.01%	237
2023 Q2	$24.6K	Buy	410 +6	+1%	+$342	0.01%	247
2023 Q1	$20K	Buy	404 +142	+54%	+$7.99K	0.01%	220
2022 Q4	$15K	Buy	+262	New	+$14.7K	0.01%	198

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

China Universal Asset Management Company's IMCR Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Immunocore (IMCR) stake by 33% in Q2 2026, selling an estimated $104K and leaving 7,277 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #342.

China Universal Asset Management Company first reported a position in IMCR in Q4 2022 and has held it in 15 quarters since. The position peaked at $524K in Q4 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

China Universal Asset Management Company held 7,277 shares of Immunocore worth $231K as of Q2 2026.
China Universal Asset Management Company sold 3,506 Immunocore shares in Q2 2026, an estimated $104K.
Immunocore made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #342 holding.
China Universal Asset Management Company first reported a position in Immunocore in Q4 2022 and has held it in 15 quarters since.
China Universal Asset Management Company's Immunocore position peaked at $524K in Q4 2025.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.